The China Fund Inc
The China Fund Inc operates in various business sectors.
The China Fund Inc (CHN) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, The China Fund Inc (CHN) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
The China Fund Inc - Net Assets Trend (None–None)
This chart illustrates how The China Fund Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for The China Fund Inc (None–None)
The table below shows the annual net assets of The China Fund Inc from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to The China Fund Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
The China Fund Inc Competitors by Market Cap
The table below lists competitors of The China Fund Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Portfolioman Pet&Par SustWo KL
CO:PMIPPSW
|
$146.88K |
|
BASLER (BSL.SG)
STU:BSL
|
$146.96K |
|
MEDION
MU:MDN
|
$147.01K |
|
R STAHL N
BE:RSL2
|
$147.02K |
|
Bellerophon Therapeutics Inc
PINK:BLPH
|
$146.79K |
|
IA Invest FormueFyn Skandi+
CO:IAIFFS
|
$146.69K |
|
VISHAY INTERTECHNOL
BE:VHY
|
$146.52K |
|
EXPRES2ION BIOTECH HLDG
F:5JD
|
$146.33K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in The China Fund Inc's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares The China Fund Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently The China Fund Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares The China Fund Inc's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.